We show that inhibiting HMG-CoA reductase using atorvastatin rescues the AGS microglial phenotypes to control conditions, a valuable finding that may be translated to other microglia-centric lipid-associated diseases such as MS and leukodystrophies. The gene discussed is HMGCR; the disease is myeloid sarcoma.